Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
TERUMO CORP UNSP/ADR (TRUMY)
NASDAQ:AMEX Investor Relations:
terumo.com/investor/library/index.html
Company Research
Source: GlobeNewswire
MELBOURNE, Australia , Feb. 19, 2026 (GLOBE NEWSWIRE) -- Q-Sera Pty Ltd, an Australian venture-backed company, today announced the first product launch of its patented evacuated blood collection technology, with the launch by Japanese medical device company, Terumo Corporation of its VenoJect II RAPClotTM blood collection tubes in the Japanese market. Q-Sera’s ecarin (RAPClot) technology involves using a certain class of proteins (prothrombin activators) originally identified from the venom of specific snakes to accelerate the clotting of blood in an improved blood collection tube to rapidly produce high quality serum for biochemical analysis, even from anticoagulated blood. Terumo Corporation has the exclusive rights to use Q-Sera’s recombinant RAPClot technology to manufacture and market its VenoJect II RAPClot tubes in Japan. The development of VenoJect II RAPClot next-generation blood collection tubes involved the scaling-up of Q-Sera’s recombinant ecarin and manufacture at c
Show less
Read more
Impact Snapshot
Event Time:
TRUMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRUMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRUMY alerts
High impacting TERUMO CORP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
TRUMY
News
- Terumo Blood and Cell Technologies introduces APAC C> Ecosystem Blueprint [Yahoo! Finance]Yahoo! Finance
- Terumo Blood and Cell Technologies introduces APAC C> Ecosystem BlueprintPR Newswire
- Terumo (TRUMY) was upgraded by Nomura to "hold".MarketBeat
- Terumo reports Q3 results [Seeking Alpha]Seeking Alpha
- Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha